Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection
- 24 January 2004
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 363 (9405), 325-327
- https://doi.org/10.1016/s0140-6736(03)15393-7
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Use of Circulating Galactomannan Screening for Early Diagnosis of Invasive Aspergillosis in Allogeneic Stem Cell Transplant RecipientsThe Journal of Infectious Diseases, 2002
- Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validationBlood, 2001
- Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective studyCancer, 2001
- Interactions Mediating Bacterial Translocation in the Immature IntestineJournal of Nutrition, 2000
- Early diagnosis of invasive aspergillosisThe Lancet, 2000
- False‐positive results in premature infants with the Platelia®Aspergillus sandwich enzyme‐linked immunosorbent assayMycoses, 1998
- Detection of Aspergillus galactomannan antigen in foods and antibioticsMycoses, 1997
- Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosisThe Pediatric Infectious Disease Journal, 1996
- 'Lipoteichoic acid' of Bifidobacterium bifidum subspecies pennsylvanicum DSM 20239. A lipoglycan with monoglycerophosphate side chainsEuropean Journal of Biochemistry, 1987
- Passage of Undegraded Dietary Antigen into the Blood of Healthy AdultsScandinavian Journal of Immunology, 1985